2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Sunitinib: new trials by email Literature Review of Sunitinib trials Research Report on Sunitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy patients with sunitinib or pazopanib - Clear-cell Metastatic Renal Cell Carcinoma | Phase 4 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 90 | 2012-12-01 | 2021-03-23 |
| Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma Sunitinib (SUTENT) - Metastatic Renal Cell Carcinoma | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 33 | 2008-12-01 | 2015-04-01 |
Carcinoma, Renal Cell (1) · Clear-cell metastatic renal cell carcinoma (1)
Assistance Publique - Hôpitaux de Paris (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)
Belgium (1) · France (1)